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Summary
Pelizaeus-Merzbacher disease (PMD) is an X-linked,
dysmyelinating disorder of the CNS. Duplications of the
proteolipid protein (PLP) gene have been found in a
proportion of patients, suggesting that, in addition to
coding-region or splice-site mutations, overdosage of the
gene can cause PMD. We show that the duplication can
be detected by interphase FISH, using a PLP probe in
five patients and their four asymptomatic carrier moth-
ers. The extent of the duplication was analyzed in each
family by interphase FISH, with probes from a 1.7-Mb
region surrounding the PLP gene between markers
DXS83 and DXS94. A large duplication x500 kb was
detected, with breakpoints that differed, between fam-
ilies, at the proximal end. Distinct separation of the du-
plicated PLP signals could be seen only on metaphase
chromosomes in one family, providing further evidence
that different duplication events are involved. Quanti-
tative fluorescent multiplex PCR was used to confirm
the duplication in patients, by the detection of increased
copy number of the PLP gene. Multiallelic markers from
the duplicated region were analyzed, since the identifi-
cation of two alleles in an affected boy would indicate
a duplication. The majority of boys were homozygous
for all four markers, compared with their mothers, who
were heterozygous for one to three of the markers. These
results suggest that intrachromosomal rearrangements
may be a common mechanism by which duplications
arise in PMD. One boy was heterozygous for the PLP
marker, indicating a duplication and suggesting that in-
terchromosomal rearrangements of maternal origin also
can be involved. Since duplications are a major cause of
PMD, we propose that interphase FISH is a reliable
method for diagnosis and identification of female
carriers.
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Introduction
Pelizaeus-Merzbacher disease (PMD [MIM 312080]) is
a rare, X-linked, neurological disorder characterized by
dysmyelination of the CNS.Mutations in the proteolipid
protein (PLP) gene have been detected in patients (re-
viewed in Hodes et al. 1993) and animal models of
PMD, including the jimpy mouse (Nave et al. 1986),
myelin-deficient (md) rat (Boison and Stoffel 1989), and
shaking pup (Nadon et al. 1990). The PLP gene is lo-
cated on chromosomeXq22 (Willard and Riordan 1985;
Mattei et al. 1986) and encodes two transcripts, known
as “PLP” and “DM20” (reviewed in Griffiths et al.
1995). PLP is an integral membrane protein that forms
a major structural component of myelin in the CNS (re-
viewed in Popot et al. 1991); DM20 is a smaller, alter-
nately spliced isoform (Nave et al. 1987) that is ex-
pressed earlier than PLP in the CNS and may have a
role in oligodendrocyte differentiation and survival. The
PLP gene also has been associated with X-linked spastic
paraplegia type 2 (SPG2) which has been suggested to
be an allelic form of PMD (Saugier-Veber et al. 1994).
A wide spectrum of mutations has been found (re-
viewed in Hodes et al. 1993), but these only account for
10%–25% of families in which the disease segregates
with the PLP locus (Boespflug-Tanguy et al. 1994). Du-
plications of the PLP gene have been detected in an in-
creasing number of patients, which suggests that over-
dosage can also be a causative mechanism for PMD (Ellis
and Malcolm 1994; Inoue et al. 1996a; Wang et al.
1997; Sistermans et al., in press). Animal models support
PLP duplications as a molecular basis for the disease,
since transgenic mice with extra copies of the wild-type
PLP gene and overexpression of the mRNA exhibit a
similar phenotype of abnormal CNS myelination and
premature death (Kagawa et al. 1994; Readhead et al.
1994; Inoue et al. 1996b). Neurological symptoms and
severity of the disease in transgenic mice correlates with
PLP-gene copy number and with the level of overex-
pression (Kagawa et al. 1994; Readhead et al. 1994;
Inoue et al. 1996b).
Techniques used to identify duplications involving the
PLP gene in PMD patients include increased dosage on
Southern blots (Ellis and Malcolm 1994; Sistermans et
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al., in press), comparative multiplex PCR (CM-PCR)
(Inoue et al. 1996a;Wang et al. 1997), quantitative PCR
(Sistermans et al., in press), and densitometric RFLP
analysis (Inoue et al. 1996a; Wang et al. 1997). In the
present study, we have detected PLP-gene duplications
by interphase-nuclei FISH and have detected increased
gene dosage, by quantitative fluorescent multiplex PCR.
We confirm that PLP overdosage is an important genetic
abnormality in PMD and show that interphase FISH is
a reliable technique that will facilitate diagnosis and car-
rier detection. We have characterized the duplication
breakpoints in four families and suggest origin and
mechanisms for the rearrangements. Similarities be-
tween PMD and Charcot-Marie-Tooth disease type 1
(CMT1A) are apparent. CMT1A is the most common
subtype of the hereditary motor and sensory neuropa-
thies (HMSN) and is also known as “HMSN1.” The
majority of patients have a partial duplication of chro-
mosome 17p11.2, which includes the peripheral myelin
protein 22 (PMP-22) gene (Timmerman et al. 1992).
The importance of gene dosage in myelin disorders is
highlighted.
Subjects and Methods
Subjects
Four families (DH, NO, DB, and ND) were studied
that included five affected boys diagnosed, by referring
neurologists, as having PMD. All mothers were asymp-
tomatic. Families DH and NO have been described in a
previous study (Ellis and Malcolm 1994), and, on the
basis of pedigree information, mother DH is an obligate
carrier. Ten normal female controls and 10 normal male
controls were used for the fluorescent quantitative mul-
tiplex PCR. For eachmultiplex assay, 6–16 controlswere
included, with an equal number of males and females.
One normal female control was used for the FISH.
Methods
Metaphase-Chromosome and Interphase-Nuclei
Preparation
Lymphoblastoid cell lines from families DH, NO, and
DB were cultured according to standard methods. Prior
to being harvested, the cells were starved for 5–8 d, to
block the cells in the G0 phase of the cell cycle. Cultures
were then exposed to colcemid and were harvested ac-
cording to a standard protocol, to produce metaphase
chromosomes in addition to interphase nuclei. Prepa-
rations from family ND and from mother DB were ob-
tained from peripheral blood lymphocytes by a thymi-
dine-synchronized technique (Wheater and Roberts
1987).
Clones Mapped by FISH
Cosmids and PAC clones in this study were from con-
tigs mapping to Xq22 (E.K., unpublished results), which
contained the following loci: DXS83, DXS101c,
DXS1106, DXS54, PLP, DXS1191, and DXS94. The
cosmids are from the Lawrence Livermore flow-sorted
X-chromosome library (gift of P. de Jong) and were iso-
lated by use of whole YACs as hybridization probes,
which originated from a complete YAC contig of the
region (Kendall et al. 1997). The two PACs were from
a whole-genome library (P. de Jong, Lawrence Livermore
National Laboratory) (Ioannou et al. 1994) isolated by
use of smaller specific probes. Contigs were assembled
around the known marker loci, by a combination of
hybridization using cosmid ends generated by vectorette
PCR (E.K., unpublished results) and fingerprinting (G.
Howell, personal communication). The coordinate num-
bers for clones mapped by FISH are shown in figure 1.
All clones were positive for the respective markers, ex-
cept dJ79p11, dJ198p4, and U65A4. PAC dJ79p11 was
deduced to be positive for DXS101c, by contig infor-
mation. Contig analysis using cosmid length to estimate
physical distance suggested that dJ198p4 and U65A4
were ∼20–40 kb from DXS83 and DXS101c,
respectively.
FISH
Miniprep DNA was prepared by a standard technique
and was labeled with either biotin-16-dUTP or digoxi-
genin-11-dUTP, by nick translation. FISH was per-
formed as described elsewhere (Fitzgibbon et al. 1993),
except that PAC probes required a threefold increase in
COT1 DNA, for competition of repeat sequences. Rou-
tine hybridizations included a biotin-labeled cosmid or
PAC probe and a digoxigenin-labeled X chromo-
some–specific centromeric probe, to confirm hybridiza-
tion efficiency and X-chromosome number. Biotin-la-
beled probes were detected by use of FITC conjugated
to avidin, and the centromeric probe, labeled with di-
goxigenin, was detected by use of rhodamine conjugated
to anti-digoxigenin. For two-color FISH using two cos-
mid probes, the X-centromeric probe was not included,
and the signal for the digoxigenin-labeled probe was
amplified with Texas Red conjugated to anti-sheep IgG.
Cells were counterstained with DAPI and were viewed
by use of a Zeiss Axiophot fluorescent microscope with
a triple-bandpass filter.
Probes were hybridized to slides from patients, car-
riers, and controls. Metaphase chromosomes were in-
spected to confirm that there was successful hybridiza-
tion to Xq22, and then the hybridization patterns of
60–100 nuclei were scored per slide. Nuclei with the
expected number of red centromeric signals (i.e., one for
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Figure 1 Physical map of Xq22, showing the extent of the duplication involving PLP in four PMD families (NO, ND, DH, and DB), as
detected by interphase FISH. The four families were analyzed by two PACS (“dJ” prefix) and six cosmids (“u” prefix) from a 1.7-Mb region
containing PLP. The minimum region of duplication in each family is shown by the thicker black line. Probes from this interval that were
analyzed were duplicated. For each family, the maximum extent of the duplication is indicated by a dotted line with an arrowhead at both
ends; the arrowheads point to probes that were not duplicated. The duplication in family DB differs because it can be resolved on metaphase
chromosomes (see fig. 2D). All probes were positive for their respective marker locus, except for dJ198p4, dJ79p11, and U65A4. Contig
information suggests that dJ79p11 contains DXS101c and that clones dJ198p4 and U65A4 are 20–40 kb from their associated markers.
Distances between most markers were obtained from a PFGE map described by Vetrie et al. (1994). The positions of DXS1106 and DXS1191
were deduced on the basis of contig information (data not shown).
males and two for females) and with at least one green
signal were analyzed. Each nucleus was scored on the
basis of the number of green signals that it contained
and on the relative positions of the latter. A result was
obtained if 160% of these scores fell into either the du-
plicated or nonduplicated category. In male nuclei, a
single signal indicated a nonduplicated probe, and two
adjacent signals indicated a duplication; in female nuclei,
two signals with a large distance between them indicated
a nonduplicated probe, and two adjacent signals plus
another elsewhere in the nucleus indicated a duplication.
If DNA replication or poor hybridization caused any
question with regard to the classification, the experiment
was repeated.
DNA Isolation and Analysis of Multiallelic Markers
Genomic DNAwas extracted from either whole blood
(in the case of the controls and families ND and DB) or
lymphoblastoid cell lines (in the case of families NO and
DH), according to standard procedure. Genomic DNA
for each individual was analyzed by fluorescent PCR
using four polymorphic microsatellite markers from the
largest region found to be duplicated by FISH. The
markers included the dinucleotide-repeat polymorphism
in intron 1 of the PLP gene (Mimault et al. 1995) (het-
erozygosity .69), DXS1106 (Dib et al. 1996) (heterozy-
gosity .672), DXS8096 (Dib et al. 1996) (heterozygosity
.8), and DXS1191 (Dib et al. 1996) (heterozygosity .65).
Relative positions of markers on Xq22 are shown in
figure 1.
Quantitative Fluorescent Multiplex PCR
The multiplex PCR was adapted from a method de-
scribed by Inoue et al. (1996a). The sensitivity was im-
proved by use of a fluorescent labeling strategy, rather
than ethidium bromide staining. An automated DNA
sequencer was used to quantify the fluorescently labeled
multiplex PCR products. Only a small amount of prod-
uct is required for analysis, and therefore a low cycle
number can be used. Preliminary experiments to deter-
mine optimum cycle number showed that at 18 cycles
the amplification reactions were exponential and that
the amount of PCR product generated was directly pro-
portional to the copy number of the target sequence.
Three pairs of primers were used for the multiplex
PCR. Two pairs of primers were from the PLP gene; one
of these pairs amplified the dinucleotide-repeat poly-
morphism (CA-PLP1 and CA-PLP2) (Mimault et al.
1995), and the other amplified exon 7 (PM-7A and PM-
7B) (Osaka et al. 1995). The third pair of primers
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(PRP44 and PRP200A) amplified exon 2 of the prion
protein gene (PRNP), which was used as a control gene
(Inoue et al. 1996a). The forward primers were labeled
with the fluorescent phosphoramidite 6-FAM, at the 5′
end.
Multiplex PCR was performed with 75 ng DNA, 1#
AmpliTaq Gold PCR buffer (Perkin-Elmer), 200 mM
each dNTP, 1.5 mM MgCl2, 10 pmol each of primers
PRP44 and PRP200, 1.9 pmol each of primers PM-7A
and PM-7B, 5 pmol each of primers CA-PLP1 and CA-
PLP2, and 0.75 U AmpliTaq Gold enzyme (Perkin-El-
mer), in a 10-ml volume. Conditions for amplification
were 94C for 10 min, to activate the AmpliTaq Gold
enzyme and to denature; 18 cycles of 1 min at 94C, 1
min at 55C, and 1 min at 72C; and a final extension
for 10 min at 72C. Products were analyzed on an ABI
377 DNA sequencer using GENESCAN and GENO-
TYPER software (ABI). Electrophoretograms were pro-
duced for each reaction, with three peaks representing
the three PCR products. GENOTYPER software was
used to calculate both the size, in base pairs, of each
product and the area under the peak, which correlates
to the quantity of fluorescent signal incorporated by the
labeled primers. Dosage estimates for PLP were obtained
by comparison of the PLP peak area with the peak area
of the PRNP internal control fragment, within each in-
dividual fluorescence profile. Two ratio values were
thereby obtained for each sample: the ratio PLP CA:
PRNP and the ratio PLP exon 7:PRNP. Normal male
and female controls were used to obtain a reference
range, for samples with one and two PLP alleles, re-
spectively. The variance in control numbers was 6–16
in six experiments. Samples were analyzed two to four
times, to allow for experiment variability, and the PLP:
PRNP ratios were compared with those for normal
controls.
Results
Identification of Xq22 Duplication, by FISH
Figure 2 shows the duplicated signals for a cosmid
containing PLP detected by interphase FISH in an af-
fected male (fig. 2A) and his mother (fig. 2B), who is an
obligate carrier of PMD. The affected male has two ad-
jacent yellow signals, which indicate the duplication, and
one red signal, which confirms a single X chromosome.
Three yellow signals are seen for the female carrier—two
adjacent signals indicating the duplication and a third
signal elsewhere in the nucleus from the normal chro-
mosome; two red signals confirm the presence of two X
chromosomes. The PLP duplication was detected in all
five PMD patients and in their four asymptomatic moth-
ers. The hybridization signals could not be resolved on
metaphase chromosomes from three families, which sug-
gested that the size of the duplication was !1 Mb (fig.
2C) (Trask et al. 1991). In contrast, easily resolvable
hybridization signals identified the duplication on met-
aphase chromosomes in family DB (fig. 2D). A greater
distance between duplicated PLP hybridization signals
was also observed in interphase nuclei from family DB
(fig. 2E). This suggests that a larger rearrangement is
involved and that the duplication causing PMD differs
between families.
Characterization of Extent of Xq22 Duplication
Probes proximal and distal to the PLP gene, covering
a region of ∼1.7 Mb, were mapped, by FISH, onto in-
terphase nuclei and metaphase chromosomes from the
four carrier mothers. Cosmid and PAC probes have been
assembled into contigs with marker loci (E.K., unpub-
lished data). The order and distance betweenmostmark-
ers was determined by construction of a PFGE physical
map (Vetrie et al. 1994). This was used to estimate the
maximum and minimum sizes of the duplication. Results
of the interphase FISH experiments using two PACs and
six cosmids are presented in figure 1. The extent of the
duplication in each family, with respect to physical dis-
tances on Xq22, is shown.
We show that the minimum size of the duplication is
∼500 kb in families DB and DH and ∼800 kb in families
NO and ND. The distal breakpoint mapped between
cosmids U240C2 (DXS1191) and U144A10 (DXS94),
in all four families. Since these markers are ∼400 kb
apart, more cosmids from this region will be required
in order to refine the position of the distal breakpoints
further. The proximal breakpoints for the duplication
were found to differ between families. The duplication
in family NO was found to extend the most proximal,
with the breakpoint mapping between dJ198p4 (contig
containing DXS83) and dJ79p11/U65A4 (contig con-
taining DXS101c). The proximal breakpoint in family
ND mapped between dJ79p11/U65A4 (contig contain-
ing DXS101c) and U97D2 (DXS1106); in families DH
and DB, it was positioned between U97D2 (DXS1106)
and U92G2 (DXS54). Examples of the differences in
proximal breakpoints are presented in figure 2. We show
that cosmid U65A4 (DXS101c) is duplicated in family
NO (fig. 2F) but not in family DH (fig. 1G). We also
show that cosmid U97D2 (DXS1106) is duplicated in
family NO (fig. 2H and I) but not in family DB (fig.
2E).
An unusual rearrangement is thought to have occurred
in family DB, because the duplicated signals could be
clearly separated on metaphase chromosomes (fig. 2D).
However, the extent of the duplication appears the same
as that for family DH and smaller than that for families
NO and DB. Further characterization of the rearrange-
Figure 2 Interphase FISH using cosmids from Xq22. A, Interphase nucleus from patient DH, hybridized with a biotin-labeled PLP cosmid
(U125A1) (yellow) and a digoxigenin-labeled X-centromeric probe (red). The two yellow signals indicate a PLP duplication. B, Interphase
nucleus from mother DH, hybridized with a biotin-labeled PLP cosmid (U125A1) (yellow) and a digoxigenin-labeled X-centromeric probe (red).
The two adjacent yellow signals indicate a PLP duplication, and the single yellow signal indicates the normal X chromosome. C, Two X
chromosomes from a metaphase spread from mother ND. The red signal indicates the centromere, and the yellow signal indicates the PLP
cosmid probe. The larger PLP hybridization signal on the left chromosome suggests that it may carry the duplication. D, Two X chromosomes
from a metaphase spread from mother DB. The red signal indicates the centromere, and the yellow signal indicates cosmid U92G2 (DXS54),
which is ∼150 kb proximal to PLP (see fig. 1). An obvious duplication is shown on the left chromsome. E, Interphase nucleus from mother
DB, hybridized with a digoxigenin-labeled PLP cosmid (U125A1) (red) and a biotin-labeled DXS1106 cosmid (U97D2). The duplicated PLP
signals (red) are farther apart than those found in family HD (see A and B). Cosmid U97D2 was not duplicated. F, Interphase nucleus from
mother NO, hybridized with biotin-labeled cosmid U65A4 (yellow) and a digoxigenin-labeled X-centromeric probe (red). The two adjacent
yellow signals indicate that the cosmid is duplicated, and the single yellow signal indicates the normal X chromosome. G, Interphase nucleus
from mother DH, hybridized with biotin-labeled cosmid U65A4 (yellow) and a digoxigenin labeled X-centromeric probe (red). The two yellow
signals at either side of the nucleus show that the cosmid is not duplicated.H, Interphase nucleus from mother NO, hybridized with digoxigenin-
labeled U65A4 cosmid (red) and biotin-labeled U97D2 cosmid (yellow). The yellow-red-yellow-red pattern suggests a duplication in a head-
to-tail arrangement. The adjacent red and yellow signals indicate the normal X chromosome. I, Interphase nucleus from mother NO, hybridized
with digoxigenin-labeled PLP cosmid (red) and biotin-labeled U97D2 cosmid (yellow). The yellow-red-yellow-red pattern suggests a duplication
in a head-to-tail arrangement. The adjacent red and yellow signals indicate the normal X chromosome.
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Figure 3 Plots of ratio PLP CA:PRNP against ratio PLP exon 7:PRNP, obtained by quantitative PCR for controls, patients, and mothers.
A, Family DH. B, Family NO. C, Family DB. D, Family ND.
ment is required, and the possibility of a PLP duplication
with an insertion event is being investigated.
Orientation of the Duplication
Two-color interphase FISH was used to orient the du-
plication in a head-to-tail direction in family NO, as
shown in figure 2H and I. Cosmids U65A4 and U97D2
were labeled with digoxigenin and biotin, respectively,
and were hybridized onto cells from the carrier mother.
Nuclei showed four signals together in a red-yellow-red-
yellow order, indicating a tandem duplication, and a pair
of signals elsewhere in the nucleus, one red and one
yellow, which were from the normal X chromosome. As
expected, the signals could not be resolved onmetaphase
chromosomes, because the probes were too close. Cos-
mids U125A1 and U97D2 were also hybridized together,
and the same pattern was observed after detection by
two-color FISH.
Identification of Duplication by Quantitative
Fluorescent Multiplex PCR
Two PLP:PRNP-ratio values were generated for each
sample, and these were plotted against each other and
are shown in figure 3. There was distinct separation of
PLP:PRNP ratios for male and female controls (fig. 3),
and the mean values were calculated to be 0.4:1 and
0.8:1, respectively (table 1). As expected, the ratio for
females was twice that for the male controls; these ratios
corresponded to one and two copies of the PLP gene,
respectively. These values provided controls for com-
parison with the ratios obtained for patients and their
mothers. Although there was considerable scatter in the
ratios, the PLP:PRNP ratios for the affected males were
always greater than those for normal males and fell into
or above range for normal females (fig. 3A–D). These
results indicate that the five PMD patients have an in-
creased dose of the PLP gene and confirm the PLP du-
plication detected by FISH in all four families.
The quantitative PCR was less reliable for detection
of female carriers with three copies of the PLP gene (see
table 1). The quantitative-PCR result for mother DB
showed that the PLP-gene dosage was the same as that
for normal females and therefore conflicted with the du-
plication detected by interphase FISH (fig. 2D and E).
However, karyotyping of metaphase chromosomes from
peripheral blood from this individual has identified a
more complex mosaic rearrangement, and further char-
acterization is ongoing.
Table 1 shows the differences, in mean PLP:PRNP
ratios, that were found between the PMD families. The
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Table 1
Dosage Estimates Obtained by Quantitative Multiplex PCR, and
Comparison with Duplication Detection by Interphase FISH
SAMPLE
PLP:PRNP RATIO
DOSAGE ESTIMATE,
BY PCR
INTERPHASE
FISH
RESULTMean Normalized
Controls:
Male .39 .49 One copy PLP (1#) Normal
Female .79 1.00 Two copies PLP (2#) Normal
Patients:
DH 1.34 1.70 Overdosage (3#) Duplication
NO .88 1.11 Overdosage (2#) Duplication
DB .94 1.19 Overdosage (2#) Duplication
ND-1 1.08 1.37 Overdosage (2.8#) Duplication
ND-2 .94 1.19 Overdosage (2#) Duplication
Mothers:
DH 1.89 2.39 Overdosage (4.8#) Duplication
NO 1.00 1.27 Two or three copies
PLP (2.6#)
Duplication
DB .88 1.11 Normal (2#) Duplication
ND 1.23 1.56 Overdosage (3#) Duplication
NOTE.—PLP:PRNP values were normalized to give a ratio of 1 for
female controls and a ratio of ∼.5 for male controls. By comparing
normalized ratios for controls and patients, dosage estimates for the
fluorescent quantitative PCR were obtained (the numbers in paren-
theses represent the number of copies of the PLP gene, as indicated
by PCR). These results are compared with those for interphase FISH
(with duplications as indicated).
normalized ratio for patient DH and his mother were
much greater than expected for a duplication of the PLP
gene. The increased dosage in family DH compared with
that in family NO has also been reported by Ellis and
Malcolm (1994), who used quantitative Southern anal-
ysis. The overdosage suggests that this family may have
a triplication of the PLP gene, but this is not supported
by interphase FISH. The results for the interphase FISH
are shown in figure 2A and B. The boy clearly shows
only two hybridization signals, and themother has three.
Multiallelic Markers
Polymorphic markers from an intron of the PLP gene
and from within the duplicated region (fig. 1) were an-
alyzed to try to identify multiple alleles that would in-
dicate a duplication. The observed heterozgosities for
these markers are .65–.8. Only one patient (DB) showed
two alleles for any marker. The mothers were hetero-
zygous for one to three of the four markers analyzed
(table 2). In accordance with the data on females, eight
female controls analyzed were heterozygous for an av-
erage of two or three markers (data not shown).
Discusssion
Duplication of the PLP gene is clearly a frequent form
of mutation in PMD, and it has been suggested that
duplications may bemore common than pointmutations
in PLP (Inoue et al. 1996a;Wang et al. 1997; Sistermans
et al., in press). We have shown that interphase FISH is
a reliable technique for detection of PLP duplications in
patients and their carrier mothers.
We have shown that the duplicated segment is large,
500 ! 1,650 kb. The proximal breakpoint was shown
to differ between families but was x150 kb from the
PLP gene. The distal breakpoint was found to be con-
stant, on the basis of the cosmids tested in this study,
and was x350 kb from the PLP gene. This finding sup-
ports previous work, which had shown that the dupli-
cation does not interrupt either the coding sequence of
the PLP gene or the immediately flanking regions (Ellis
and Malcolm 1994). It suggests that increased dosage
of the gene, rather than disruption of PLP coding or
regulatory regions, is responsible for the clinical phe-
notype. The overexpression of the DM20 transcript in
two brothers with PMD, which has been reported by
Carango et al. (1995), supports this idea. It is also in
line with evidence in PLP-transgenic mice (Kagawa et
al. 1994; Readhead et al. 1994; Inoue et al. 1996b). The
duplication was not found to extend to another locus
on Xq21, which is reported to map between markers
DXS3 and DXS106 in a single family with PMD-like
disease (Lazzarini et al. 1997). These markers are prox-
imal to the area that we have shown to be duplicated;
and, therefore, a mutation in a second gene within the
duplication cannot be the molecular basis for disease in
this family.
Quantitative fluorescent PCR could confirm the du-
plications in all five PMD patients. However, reproduc-
ible results confirming increased dosage could not be
obtained in all carrier mothers, either in this study or in
others (Sistermans et al., in press). The accuracy and
sensitivity of the quantitative assay can be affected by a
number of factors, including the nonuniform amplifi-
cation of loci and the quality and source of genomic
DNA. This may be the reason why conflicting PCR and
FISH results were obtained for mother NO, who already
had been known to be a carrier (Ellis and Malcolm
1994). The inconsistency between results obtained by
different methods, for mother DB, is probably explained
by a further mosaic rearrangement detected during kar-
yotyping of metaphase chromosomes from peripheral
blood. More-extensive analysis will be required in order
to determine the complex rearrangements in this
individual.
One family (DH) consistently gave results suggesting
a triplication of the PLP gene. This was true for both
the patient and his mother, who was an obligate carrier,
whether measured by quantitative PCR (table 1) or the
earlier quantitative Southern blot (Ellis and Malcolm
1994). The suggestion of a triplication is not supported
by interphase FISH (fig. 2A and B), in either the mother
or the child. If the patient has three copies of the PLP
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Table 2
Analysis of Multiallelic Markers from Duplicated Region in PMD
SAMPLE
ALLELE SIZE(S) [bp]/ DUPLICATION STATUS OFa
DXS1106 DXS8096 PLP DXS1191
Patient DH 178/ 235/? 136/ 243/
Mother DH 178 and 180/ 235/? 136/ 243/
Patient NO 180/ 235/ 134/ 243/
Mother NO 174 and 180/ 235/ 134/ 239 and 243/
Patient DB 180/ 258/? 134 and 146/ 243/
Mother DB 180/ 256 and 258/? 134 and 146/ 243/
Patient ND-1 180/ 258/ 136/ 239/
Patient ND-2 180/ 258/ 136/ 239/
Mother ND 178 and 180/ 235 and 258/ 136/ 239 and 243/
a The extent of the duplication in each family is shown, to identify informative markers.
Cosmid probes for PLP, DXS1106, and DXS1191, which were found, by FISH, to be
duplicated and which therefore are informative are denoted by a plus sign (), and those
probes not duplicated in each family and therefore uninformative are denoted by a minus
sign (). DXS8096 is positioned between DXS1106 and DXS54, but a cosmid probe was
unavailable. DXS8096 was assumed to be informative in families NO and ND, because
it was contained within the duplication; since we do not know whether it is duplicated in
families DH and DB, the status is represented by a question mark (?).
gene on his X chromosome, then two copies must be so
close together that they cannot be resolved by interphase
FISH. Since the PLP gene is x150 kb from either break-
point, this would not be predicted in either a head-to-
tail or a head-to-head orientation. The interphase FISH
did not show consistent evidence of one hybridization
signal of greater intensity than the other (fig. 2A and B).
Further analysis of the rearrangement in this family is
ongoing. It is noteworthy that patient DH was the most
severely affected of those studied. He had the connatal
form of the disease and died at age 10 mo.
Another potential method of establishing a duplica-
tion is detection of heterozygosity in affectedmales, after
analysis of several multiallelic markers across the region.
This approach has been used to detect the 1.5-Mb du-
plication in autosomal dominant CMT1A, by the pres-
ence of three alleles at one or more marker loci (Lupski
et al. 1991; Thomas et al. 1997) or by dosage differences
between two RFLP alleles (Lupski et al. 1991; Raey-
maekers et al. 1991; Thomas et al. 1997). However,
despite the use of four markers with heterozygosities of
.65–.8, four of five boys with PMD were homozygous
for all markers detected. In three boys, the duplication
covered all four markers. In the other two boys (DB and
DH), two markers were confirmed to be in the dupli-
cated region, and one was outside it. In contrast, each
of 12 women analyzed either because they were poten-
tially carrier mothers or as normal controls was hetero-
zygous for an average of two to three markers. Similarly,
of four boys with duplications reported by Inoue et al.
(1996a), none were heterozygous for the less informative
AhaII polymorphism in exon 4 (heterozygosity .33)
(Trofatter et al. 1991), whereas three of the four mothers
were heterozygous. The tendency toward homozygosity
strongly suggests that both duplicated alleles are usually
derived from the same chromosome and that the dupli-
cation may have arisen by an intrachromosomal event.
Unfortunately, the results show multiallelic marker anal-
ysis to be an unsuitable method for detection of dupli-
cations in PMD patients.
Heterozygosity of a CA-repeat marker was found in
only one patient. Two alleles were detected for the in-
tronic PLP marker (Mimault et al. 1995) in patient DB.
There are other unusual features of the duplication in
this family. Although it is smaller than the duplication
in two other families (NO and ND), the duplicated sig-
nals are reproducibly separated by a greater distance in
interphase FISH, and this is the only family in which
separate signals can be seen onmetaphase chromosomes.
This suggests that it is not a simple head-to-tail orien-
tation. It is possible that there has been a mutation in
the length of the CA repeat, because of slippage during
replication, and that the duplication may have originally
contained identical alleles. However, these events are
rare, and a more likely explanation is that the dupli-
cation arose originally in a female, by recombination
between two X chromosomes. No other family members
are available to allow us to study this point. One other
example of a boy heterozygous for a polymorphism
within PLP has been reported (Hodes et al. 1993). This
finding also suggests that interchromosomal events may
be involved in duplications causing PMD.
In all 11 of the families reported thus far, the PLP
duplication has been present in the mothers (Inoue et al.
1996b;Wang et al. 1997; present study). There have not
been any de novo events observed. This is of relevance
for genetic counseling and suggests that the rearrange-
ments originate in a male. Confirmation of origin of the
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duplication can be obtained only by extension of hap-
lotype analysis to further generations, but, unfortu-
nately, grandparental samples currently are unavailable.
Since there was no association between a particular hap-
lotype and the duplication, and because the extent of
the duplication varied between families, the origin of
the rearrangement in each family is thought to be
independent.
There is a growing list of genetic disorders resulting
from aneusomies, either duplications or deletions, in the
megabase range. In most cases, the chromosomal rear-
rangement is mediated by unequal crossover, through
misalignment of homologous low-copy-number repeats
located within and flanking the region. CMT1A and
hereditary neuropathy with liability to pressure palsies
(HNPP) result from duplications and deletions, respec-
tively, of a 1.5-Mb segment, on chromosome 17p11-12,
which is flanked by two homologous sequences,
CMT1A-REP (Pentao et al. 1992; Chance et al. 1994;
Kiyosawa et al. 1995; Kiyosawa and Chance 1996).
Smith-Magenis syndrome (SMS) patients have a com-
mon deletion, spanning ∼5 Mb, resulting from homol-
ogous recombination between low-copy-number repeats
found in three copies in the critical region (Chen et al.
1997). In CMT1A, HNPP, and SMS, junction fragments
can be detected by pulsed-field gel electrophoresis (Raey-
maekers et al. 1992; Chen et al. 1997). In CMT1A and
HNPP, there is a recombination hot spot between the
CMT1A-REPs, which can be detected by Southern blot-
ting (Kiyosawa and Chance 1996; Reiter et al. 1996).
In contrast, limited heterogeneity of the breakpoints has
been found at both ends of the Angelman syndrome/
Prader-Willi syndrome region (Knoll et al. 1990; Chris-
tian et al. 1995; Huang et al. 1997).
PMD can be compared to CMT1A, since both du-
plications and point mutations in the PMP-22 gene cause
the disease. However, in the majority of cases, a common
1.5-Mb duplication is detected (Lupski et al. 1991;
Raeymaekers et al. 1991; Nelis et al. 1996), which is
generated by a paternal interchromosomal recombina-
tion event (Palau et al. 1993; Lopes et al. 1998). There
are only a few reports of alternatively sized duplications
involving the PMP-22 gene (Ionasescu et al. 1993; Val-
entijin et al. 1993). Recent analysis of a series of de novo
cases of CMT1A and HNPP has shown that, in the four
cases of HNPP, there were only one deletion of paternal
origin (inter- or intrachromosomal origin unknown) and
three deletions of maternal origin (one of unknown or-
igin and two intrachromosomal events). Of the dupli-
cations giving rise to CMT1A, 34 of 36 were of paternal
origin; 32 of these 34 could be proved to involve both
chromosome 17 homologues, and 2 were of maternal
origin and were, again, intrachromosomal (Lopes et al.
1998). Thus, the hypothesized deletion that would be
the reciprocal of the duplication is actually a very in-
frequent event, and the mechanism of rearrangement is
sex dependent, with most of the de novo maternal events
being intrachromosomal.
In the PMD families presented in the present study or
in the literature, there has been no example of the du-
plication arising de novo, so the origin can be tested
only indirectly. All mothers tested were carriers, and at
least one of the grandmothers was also a carrier, since
she had had an affected son. This suggests that the mu-
tation may frequently arise in sperm. If this is the case,
then, since males have only one X chromosome, the
duplication would have to be intrachromosomal. This
is in agreement with the observed tendency toward ho-
mozygosity of polymorphic markers in affected boys,
which suggests that both duplicated alleles are usually
derived from the same chromosome and that the dupli-
cation may have arisen by an intrachromosomal event.
There has been one report of a complete deletion of the
PLP gene on chromosome Xq22, a deletion that also
gives rise to PMD (Raskind et al. 1991). A deletion of
x29 kb has been reported, which suggests that it is
unlikely to be an event reciprocal to the duplication that
causes PMD. If, as we suggest, intrachromosomal re-
arrangements are more common, then a reciprocal de-
letion may be rare and also could be incompatible with
life.
In summary, we have demonstrated that duplications
involving the PLP are a cause of PMD. We have shown
that the duplications are best detected by interphase
FISH, especially in female carriers. Detection of dupli-
cations in both patients and female carriers is important
for genetic counseling. Unfortunately, analysis of mul-
tiallelic markers is not diagnostically useful, since most
duplications are intrachromosomal and, therefore, the
markers are not heterozygous. Further refinement of the
duplication breakpoints will enable us to understand
both the mechanism of the rearrangement and the extent
of phenotypic difference between families. Analysis of
other transcripts from the region is also in progress, since
there may be modifier genes that play a role in affecting
the severity of the disease.
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